When I was diagnosed with Parkinson’s in August 2019, a doctor told me that Sinemet (Levodopa/Carbidopa), the starter drug of ...
The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...
The 78-year-old broadcaster lifted the lid on how he has been coping with the health news, as well as sharing his opinion on ...
Carl Parkinson and his accomplices assaulted a member of staff after stealing hundreds of pounds of designer goods ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Aerobic exercise has been linked with Parkinson's disease progression and risk. ( Washington Post) Air purifiers in residential aged-care facilities did not reduce the incidence of acute respiratory ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
GSK has licensed a small molecule for Parkinson's and is teaming up on additional targets for the disease and another ...
GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...
GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback